An Acupuncture Study for Breast Cancer Survivors With Joint Pain on Hormonal Therapies

Memorial Sloan Kettering Cancer Center (MSK)

Status

Enrolling

Conditions

Breast Cancer Stage II

Breast Cancer

Breast Cancer Stage IIIc

Breast Cancer Female

Breast Cancer Stage I

Breast Cancer Stage III

Breast Cancer Stage IIIB

Breast Cancer, Male

Treatments

Procedure: Acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT06814977

24-305

Details and patient eligibility

About

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for breast cancer survivors with joint pain on hormonal therapies.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

English- or Spanish-speaking
Black, Asian, and/or Hispanic women with a history of stage I, II, or III BC (transgender males are eligible to enroll)
No evidence of current BC disease
Receiving AI for at least 28 days with plan to continue for another 14 weeks
Worst pain rated ≥4 on a 0-10 scale in the preceding week
≥15 days with pain in the past 30 days
Pain lasting ≥1 month
Pain attributed to AI as reported by the patient
Willing and able to complete questionnaires and other study activities
Willing and able to provide informed consent for the trial

Exclusion criteria

All Stage IV Cancer
Active oncological disease
Completed chemotherapy, surgery, or radiation <4 weeks prior to study
Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)
Procedures involving affected joints within the last month or planned in the next 14 weeks
Acupuncture use for pain in the past year
Implanted electronic device (e.g., pacemaker)